Kamada KMDA
NASDAQ KMDA
$7.97 +0.08 (+1.01%)
At close: Aug 20, 2026 · 11:56 AM UTC

Kamada (KMDA) Cash from Financing Activities (2013 - 2026)

Kamada's (KMDA) quarterly Cash from Financing Activities came in at -$856000.0 in Q1 2026, down 192.15% YoY from $928918.5 in Q1 2025, and up 27.4% on a QoQ basis from -$1.2 million in Q4 2025.

Kamada (KMDA) Cash from Financing Activities (2013 - 2026) Analysis & Trends

Kamada (KMDA) has 14 years of Cash from Financing Activities data on file, last reported at -$856000.0 in Q1 2026.

  • Quarterly Cash from Financing Activities fell 192.15% year-over-year to -$856000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.9 million (down 123.37% YoY) and the FY2025 annual result came in at -$18.3 million, down 31.87% from the prior year.
  • Cash from Financing Activities rose to -$856000.0 in Q1 2026, from -$1.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $31.3 million in Q3 2023 to a low of -$16.1 million in Q2 2025.
  • A 5-year average of -$961184.8 and a median of -$1.6 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 1384222.07% — and 2024, when it tumbled 199101.67%.
  • Tracing KMDA's Cash from Financing Activities over 5 years: stood at -$2.9 million in 2022, then surged by 44.93% to -$1.6 million in 2023, then surged by 55.22% to -$708000.0 in 2024, then sank by 66.53% to -$1.2 million in 2025, then climbed by 27.4% to -$856000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$856000.0 (Q1 2026), -$1.2 million (Q4 2025), and -$754000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn -1.00 Mn
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn -813.00 Mn
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn -1.13 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 122.40 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -1.24 Bn
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 63.40 Mn
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn -74.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - -
10 Kamada 457.71 Mn 428.24 Mn 22.47 Mn -19.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.00 Mn
Jun 30, 2026 -19.00 Mn
Mar 31, 2026 -856,000.00
Mar 31, 2026 -856,000.00
Dec 31, 2025 -1.18 Mn
Dec 31, 2025 -1.18 Mn
Sep 30, 2025 -754,000.00
Sep 30, 2025 -754,000.00
Jun 30, 2025 -16.12 Mn
Jun 30, 2025 -16.12 Mn
Mar 31, 2025 -293,000.00
Mar 31, 2025 -293,000.00
Dec 31, 2024 -708,000.00
Dec 31, 2024 -708,000.00
Sep 30, 2024 -4.79 Mn
Sep 30, 2024 -4.79 Mn
Jun 30, 2024 -2.68 Mn
Jun 30, 2024 -2.68 Mn
Mar 31, 2024 -5.74 Mn
Mar 31, 2024 -5.74 Mn